OMER Omeros Corp

NASDAQ
$17.19

Omeros Corp (OMER) is expected to report earnings on November 11, 2026, after the market close. The consensus earnings estimate is a loss of $0.05 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +3.2% since its last earnings release on August 12, 2026.

Omeros Beat Consensus Estimates
Wednesday, August 12, 2026 · 4:02 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 11
Wednesday · 4:00 PM ET
Earnings Whisper
-
vs ($0.05)
Rev est $19.3M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $17.32

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Omeros Corp

Omeros Corp is engaged in the discovery, development and commercialization of pharmaceutical products for inflammation, coagulopathies and disorders of the central nervous system.

Sector

Healthcare

Industry

Biotechnology